Instil Bio
TIL
#10472
Rank
NZ$66.65 M
Marketcap
NZ$9.83
Share price
-6.09%
Change (1 day)
-56.48%
Change (1 year)

P/E ratio for Instil Bio (TIL)

P/E ratio as of November 2026 (TTM): -0.8308

According to Instil Bio's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.830769. At the end of 2024 the company had a P/E ratio of -1.68.

P/E ratio history for Instil Bio from 2021 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2024-1.68
2022-0.3663-96.38%
2021-10.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
-5.93 613.31%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.